Best Weight Loss Medications
+1 more
Best Weight Loss Medications
Weight loss medications like Ozempic and Wegovy have become increasingly popular over the last few years. For people struggling to lose weight through diet and exercise alone, these medications offer a faster way to reach a healthy weight.
For those looking to consult with medical professionals from home, we’ve put together a list of the best weight loss medication platforms available. We’ll make it easy to choose the telehealth service that suits your needs and help you understand the process of meeting with a licensed medical provider online.
- Our recommendations are based on what reviewers say.
- 4,595,513 reviews on ConsumerAffairs are verified.
- We require contact information to ensure our reviewers are real.
- We use intelligent software that helps us maintain the integrity of reviews.
- Our moderators read all reviews to verify quality and helpfulness.
Company | Customer rating | Subscription fee (monthly) | Medication cost (monthly) | Medications available | Online support | Accepts insurance | LegitScript certified | |
---|---|---|---|---|---|---|---|---|
4.7 | No | $249-$449 | 2 | Yes | No (HSA/FSA) | Yes | Visit Site | |
1.0 | No | $79-$399 | 5 | No | No | Yes | Learn more | |
1.0 | No | $99-$399 | 5 | No | No | Yes | Learn more | |
No ratingView profile | $145 (optional) | $299-$1,000+ | 3 | Add-on | Yes (medication) | Yes | Learn more | |
4.0 | $99+ | Undisclosed | 2 | Yes | No (HSA/FSA) | Yes | Learn more | |
1.0 | $99-$129 | $229+ | 3 | Yes | Yes | Yes | Learn more | |
1.0 | $199-$569 | Included | 2 | Add-on | No (HSA/FSA) | Yes | Learn more |
Read weight loss medications reviews | ||||||
---|---|---|---|---|---|---|
Offers medical weight loss treatment and medications. Patients must qualify. Included online-only consultation and follow-up visits. Free shipping. Not available in all states. Costs $299/month to $1,499+. | ||||||
Offers 100% online access to weight loss meds. Utilizes licensed medical providers. All-inclusive, single monthly fee. Limited drug options. Not available in Mississippi or Louisiana. Insurance not accepted. Strict refund policy. | Visit Site | |||||
Telehealth service. Services endocrine issues such as weight management, blood sugar control and lower testosterone with medications delivered directly. Convenient and discreet. | Chat with a ConsumerAffairs decision guide | |||||
Offers telehealth for women. Free health assessments. All-inclusive plans. Insurance not accepted. Weight loss support unavailable in 15 states, D.C. and armed forces addresses. Expensive. Customer support by email only. | Chat with a ConsumerAffairs decision guide | |||||
Telehealth weight-loss medication, health coaching and supplements. Prescribes two medications: compounded semaglutide and compounded tirzepatide. Health coaching available. Shipping in 5-10 business days. | Chat with a ConsumerAffairs decision guide | |||||
GLP-1 prescriptions and support at $129.99/month. Medication starts at $229/month. Includes telehealth consultation with a board-certified doctor, nutrition counseling and a money-back guarantee. | Chat with a ConsumerAffairs decision guide | |||||
Customized nutrition plans to accompany weight-loss medication. Guarantees 10% of body weight loss or money back. Doctor provides a prescription for either Ozempic or compounded semaglutide after consultation. | Chat with a ConsumerAffairs decision guide | |||||
Offers treatments for weight loss, mental health, sexual health, hair loss and dermatology for men. Delivers personalized and convenient health care directly to customers. Committed to accessible and affordable health care. | Chat with a ConsumerAffairs decision guide | |||||
Telehealth platform that connects patients with prescription medication for weight loss. Provides virtual consultations. Personalized prescriptions. Direct medication delivery. Certain restrictions. | Chat with a ConsumerAffairs decision guide | |||||
Personalized weight loss plans using GLP-1 medications. Continuous support from health care providers. Virtual consultations and monthly care. Insurance concierge service for medication costs. Tailored weight management programs. | Chat with a ConsumerAffairs decision guide |
Guide sources
ConsumerAffairs writers primarily rely on government data, industry experts and original research from other reputable publications to inform their work. Specific sources for this guide include:
- Frontiers in Cardiovascular Medicine, “Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study.” Accessed Aug. 16, 2024.
- Centers for Disease Control and Prevention, “Adult Obesity Facts.” Accessed Aug. 16, 2024.
- PR Newswire, “Novo Nordisk receives FDA approval for Saxenda (liraglutide [rDNA origin] injection) for chronic weight management.” Accessed Aug. 16, 2024.
- Food and Drug Administration, “FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014.” Accessed Aug. 16, 2024.
- Mayo Clinic, “Prescription weight-loss drugs.” Accessed Aug. 16, 2024.
- The American College of Obstetricians and Gynecologists, “Obesity and Pregnancy.” Accessed Aug. 16, 2024.
- Obesity Medicine Association, “Top Weight Loss Medications.” Accessed Aug. 16, 2024.
- Current Obstetrics and Gynecology Reports, “Pharmacologic Treatment of Obesity in Reproductive Aged Women.” Accessed Aug. 16, 2024.
- UC Davis Health, “Diabetes and Related Disorders.” Accessed Aug. 16, 2024.
- Cleveland Clinic, “GLP-1 Agonists.” Accessed Aug. 16, 2024.
- The New England Journal of Medicine, “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” Accessed Aug. 16, 2024.
- The New England Journal of Medicine, “A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.” Accessed Aug. 16, 2024.
- The New England Journal of Medicine, “Tirzepatide Once Weekly for the Treatment of Obesity.” Accessed Aug. 16, 2024.
- American Family Physician, “Phentermine/Topiramate (Qsymia) for Chronic Weight Management.” Accessed Aug. 16, 2024.
- Pharmacy and Therapeutics, “Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.” Accessed Aug. 16, 2024.
- The Lancet, “GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study.” Accessed Aug. 16, 2024.
- American College of Sports Medicine. “Navigating the Impact of New Weight Loss Medications.” Accessed Aug. 16, 2024.
- Food and Drug Administration, “Drug Compounding and Drug Shortages.” Accessed Aug. 16, 2024.
- Food and Drug Administration, “Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss.” Accessed Aug. 16, 2024.
- Food and Drug Administration, “FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products.” Accessed Aug. 16, 2024.
- Health System Tracker, “How do prices of drugs for weight loss in the U.S. compare to peer nations’ prices?” Accessed Aug. 16, 2024.
- Lilly, “FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems.” Accessed Aug. 16, 2024.
- Institute for Clinical and Economic Review, “ICER Publishes Evidence Report on Treatments for Obesity Management.” Accessed Aug. 16, 2024.
- Food and Drug Administration, “Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act.” Accessed Aug. 16, 2024.
- Cleveland Clinic, “Endocrinologist.” Accessed Aug. 16, 2024.
- Diabetes, Obesity and Metabolism, “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.” Accessed Aug. 16, 2024.
- Epic Research, “Many Patients Maintain Weight Loss a Year After Stopping Semaglutide and Liraglutide.” Accessed Aug. 16, 2024.
- eClinicalMedicine, “Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.” Accessed Aug. 16, 2024.
- Obesity Medicine Association, “Does Insurance Cover Weight Loss Medication?” Accessed Aug. 16, 2024.
Thanks for subscribing.
You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.